This site is intended for health professionals only
Thursday 21 March 2019
Share |

Topic: Depression

October 2, 2018
Antidepressants have more severe withdrawal symptoms than guidelines suggest, says research

Millions of antidepressant users could experience "severe withdrawals” if they cut down or come off their medication, according to a new review.
 
The UK’s All Party Parliamentary Group (APPG) for Prescribed Drug Dependence reviewed the withdrawal affects of antidepressants across 23 existing studies and found that withdrawals are much more widespread, severe and long lasting than current guidelines suggest.
 

August 10, 2015
This article reviews what is new in major depressive disorder: from clinical trials and research, through to the clinic

 

June 18, 2014
Lundbeck has presented results about sexual functioning from a head-to-head study of Brintellix (vortioxetine) versus escitalopram in patients with well-treated major depressive disorder experiencing treatment-emergent sexual dysfunction.

Lundbeck has presented results about sexual functioning from a head-to-head study of Brintellix® (vortioxetine) versus escitalopram in patients with well-treated major depressive disorder (MDD) experiencing treatment-emergent sexual dysfunction (TESD).
Sexual dysfunction, induced by treatment, affects patient’s quality of life and is a common reason people taking antidepressants may choose to be less compliant with their treatments and then potentially experience relapse of depressive symptoms.

June 18, 2014
Lundbeck has presented results about sexual functioning from a head-to-head study of Brintellix (vortioxetine) versus escitalopram in patients with well-treated major depressive disorder experiencing treatment-emergent sexual dysfunction.

Lundbeck has presented results about sexual functioning from a head-to-head study of Brintellix® (vortioxetine) versus escitalopram in patients with well-treated major depressive disorder (MDD) experiencing treatment-emergent sexual dysfunction (TESD).
Sexual dysfunction, induced by treatment, affects patient’s quality of life and is a common reason people taking antidepressants may choose to be less compliant with their treatments and then potentially experience relapse of depressive symptoms.

October 1, 2013
H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) have jointly announced that the US Food and Drug Administration (FDA) has approved Brintellix™ (vortioxetine) for the treatment of adults with major depressive disorder (MDD), a debilitating mental health illness affecting approximately 14 million adult Americans in a given year.

 

May 20, 2013
H Lundbeck A/S (Lundbeck) and partner Takeda Pharmaceutical Company Limited (Takeda) have announced that the companies will be presenting new data on four pivotal studies on vortioxetine, a novel investigational drug under review by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of major depression. The phase III data will be presented at the 2013 Annual Meeting of the American Psychiatric Association (APA) in San Francisco, USA.

teaser

October 18, 2010
More effective treatments for depression could be developed after scientists discovered a key gene

teaser

October 2, 2009
New research published into the varenicline, a drug used by people wanting to give up smoking, has shown it does not increase the risk of self harm or depression any more than its competitors

teaser

July 30, 2009
An anonymous donation of $50,000 has caused the family of a suicide victim to drop the first personal injury case against Pfizer

teaser

July 6, 2009
Scientists from Spain have discovered a drug that reduces the painful symptoms of Trigeminal neuralgia

teaser

April 8, 2008
People who have experienced depression are 2.5 times more likely to develop Alzheimer's Disease

teaser

December 18, 2007
GlaxoSmithKline has presented an overview of its neuroscience portfolio and disease strategy at a meeting in New York

teaser

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine